Tilray Brands, Inc. (TSX:TLRY)

Canada flag Canada · Delayed Price · Currency is CAD
10.73
-0.20 (-1.83%)
At close: Feb 27, 2026
-5.88%
Market Cap 1.25B
Revenue (ttm) 1.17B
Net Income (ttm) -2.94B
Shares Out n/a
EPS (ttm) -29.13
PE Ratio n/a
Forward PE 18.91
Dividend n/a
Ex-Dividend Date n/a
Volume 478,378
Average Volume 437,644
Open 10.80
Previous Close 10.93
Day's Range 10.60 - 10.92
52-Week Range 4.85 - 32.30
Beta 2.11
RSI 46.65
Earnings Date Apr 9, 2026

About Tilray Brands

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]

Sector Healthcare
CEO Irwin Simon
Employees 2,842
Stock Exchange Toronto Stock Exchange
Ticker Symbol TLRY
Full Company Profile

Financial Performance

In fiscal year 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.

Financial numbers in USD Financial Statements

News

Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada

TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness...

2 days ago - GlobeNewsWire

Are Canadian Cannabis Stocks Ready to Rebound? 3 Names to Watch

The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum...

4 days ago - MarijuanaStocks

Canadian Marijuana Stock Picks For Investors 2026

There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uph...

8 days ago - MarijuanaStocks

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United State...

10 days ago - GlobeNewsWire

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals

NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical dist...

16 days ago - GlobeNewsWire

3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run

The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industr...

24 days ago - MarijuanaStocks

Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery,  an award-winning craft distillery and spirits brand owned by  Tilray Brands, Inc.  (NASDAQ: TLRY; TSX: TLRY), has annou...

24 days ago - GlobeNewsWire

Tilray's CC Pharma Recognized as a TOP 100 Innovator in Germany

DENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that CC Pharma, its European pharmaceut...

24 days ago - GlobeNewsWire

Tilray Brands stock has crashed—but a bullish pattern is emerging

Tilray Brands stock price continued its strong downward trend, reaching its lowest level since December 9 last year. It has crashed by over 68% from its highest level in October last year.

25 days ago - Invezz

Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced

Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing C...

25 days ago - GlobeNewsWire

Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture

ATHENS, Ga., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Terrapin Beer Co. (Terrapin), a craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced a comprehensive brand refresh.

4 weeks ago - GlobeNewsWire

Tilray Has Already Done The Hard Part

Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, dr...

4 weeks ago - Seeking Alpha

February 2026 Watchlist: Leading Canadian Cannabis Stocks

The Canadian cannabis sector continues evolving as companies adapt to shifting consumer demand and global regulations. While volatility remains common, long-term opportunities still attract patient in...

4 weeks ago - MarijuanaStocks

SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey's McGee, Thievery Corporation & Chromeo to Headline

ATLANTA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX...

4 weeks ago - GlobeNewsWire

SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer

ATLANTA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX...

5 weeks ago - GlobeNewsWire

Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio

NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering...

5 weeks ago - GlobeNewsWire

How to play cannabis stocks in 2026

President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure...

5 weeks ago - Yahoo Finance

3 Canadian Marijuana Stocks For Investors In 2026

The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this ye...

6 weeks ago - MarijuanaStocks

International Cannabis Expansion Gives Tilray Positive 2026 Outlook

Tilray reported financial performance for Q2-2026 with international sales driving growth. Tilray remains undervalued after its reverse split and after the rally over rescheduling subsided. Tilray for...

7 weeks ago - Seeking Alpha

Marijuana industry taking fight against Wall Street blockades straight to Trump

Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...

7 weeks ago - New York Post

Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript

Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript

7 weeks ago - Seeking Alpha

Tilray Stock Fires Up After Record Q2 Earnings: Here's Why

Tilray Brands, Inc.. (NASDAQ: TLRY) shares climbed in Thursday's extended trading after the company released its second-quarter earnings report, beating expectations on the top and bottom lines.

7 weeks ago - Benzinga

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock...

7 weeks ago - GlobeNewsWire

Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 Earnings

Tilray Brands, Inc. (NASDAQ: TLRY) will release earnings results for its second quarter after the closing bell on Thursday, Jan. 8, 2025.

7 weeks ago - Benzinga

Tilray Q2: High Hopes or Harsh Reality?

As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads.

7 weeks ago - Benzinga